Bodal Chemicals Ltd
Chemicals & Petrochemicals | Small Cap
Bodal Chemicals Ltd, operating within the Chemical & Petrochemicals industry, demonstrates a mixed financial performance. The company shows strong solvency and growth, driven by significant increases in revenue, operating profit, and earnings per share. Profitability is also a notable strength, supported by healthy gross profit and operating margins. However, liquidity is a significant concern, with all key liquidity ratios indicating poor short-term financial health. Efficiency is also an area of concern, with low turnover ratios for fixed assets, inventory, and receivables. The company's coverage ratios are weak, reflecting challenges in meeting interest and dividend obligations. While financial metrics show some positive signs in capital expenditures, adjusted earnings and dividends are areas of concern. Overall, Bodal Chemicals exhibits potential for growth and profitability but needs to address its liquidity and efficiency challenges to ensure long-term stability. The company's reliance on equity and strong asset growth are positive indicators, but a more balanced financial strategy is needed to mitigate risks.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsUndervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio4.20
- Profitability Ratio6.80
- Efficiency Ratio4.67
- Coverage Ratio4.40
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Bodal Chemicals Ltd, operating within the Chemical & Petrochemicals industry, demonstrates a mixed financial performance. The company shows strong solvency and growth, driven by significant increases in revenue, operating profit, and earnings per share. Profitability is also a notable strength, supported by healthy gross profit and operating margins. However, liquidity is a significant concern, with all key liquidity ratios indicating poor short-term financial health. Efficiency is also an area of concern, with low turnover ratios for fixed assets, inventory, and receivables. The company's coverage ratios are weak, reflecting challenges in meeting interest and dividend obligations. While financial metrics show some positive signs in capital expenditures, adjusted earnings and dividends are areas of concern. Overall, Bodal Chemicals exhibits potential for growth and profitability but needs to address its liquidity and efficiency challenges to ensure long-term stability. The company's reliance on equity and strong asset growth are positive indicators, but a more balanced financial strategy is needed to mitigate risks.
Overall Valuation Score
P/E RATIO (TTM)
26.28
Industry Median
22.59
Small Cap Median
21.70
P/E RATIO
50.41
P/B RATIO
0.83
Industry Median
1.76
Small Cap Median
1.77
P/S RATIO
0.54
Industry Median
0.89
Small Cap Median
0.88
Others
PEG RATIO
-2.45
EV/EBITDA RATIO
5.49
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹74.11 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company demonstrates strong growth. High growth rates in revenue, operating profit, and earnings per share indicate robust expansion and profitability. This suggests effective strategies in capturing market opportunities and enhancing shareholder value. However, it's important to ensure that this growth is sustainable and supported by efficient operations and financial stability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 67.62 | -23.41 | -11.37 | 25.09 | 15.3 |
| Operating Profit Growth Rate | 152.87 | -39.55 | -16.54 | 50.45 | -3.59 |
| Earnings Per Share (EPS) Growth | 148.1 | -64.39 | -83.17 | 188.24 | 158.5 |
| Asset Growth Rate | 20.81 | 0.33 | 7.59 | 2.54 | 0.73 |
| Net Income Growth Rate | 147.5 | -61.62 | -84.21 | 200 | 166.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios present a mixed picture. While capital expenditures are well-managed, adjusted earnings and dividends are areas of concern. Cash earnings per share and book value per share also show potential for improvement. Enhancing earnings quality and managing capital structure effectively are crucial for improving overall financial health.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 8.75 | 2.96 | 0.96 | 2.16 | 3.84 |
| Cash Earnings Per Share (Cash EPS) | 12.17 | 7.28 | 5.28 | 6.96 | 9.44 |
| Book Value Per Share | 87.67 | 86.24 | 86.56 | 88.4 | 92.56 |
| Dividend Per Share (DPS) | 0.77 | 0.09 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 156.3 | 318.8 | 233.2 | 44.5 | 4.1 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company demonstrates strong profitability. Healthy gross profit and operating margins indicate efficient cost management and strong pricing strategies. While return on assets is adequate, return on equity needs improvement. Maximizing profitability through efficient operations and effective capital allocation is crucial for sustained financial health.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.42 | 5.08 | 3.66 | 5.62 | 4.52 |
| Return on Capital Employed (ROCE) | 12 | 5 | 3 | 6 | 7 |
| Return on Equity (ROE) | 9.41 | 3.53 | 0.55 | 1.63 | 4.15 |
| Return on Assets (ROA) | 10.41 | 6.27 | 4.87 | 7.14 | 6.83 |
| Operating Margin | 10.71 | 8.45 | 7.96 | 9.57 | 8 |
| Net Margin | 4.82 | 2.41 | 0.43 | 1.03 | 2.39 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed picture. While days sales in inventory and receivable days indicate efficient inventory and credit management, low turnover ratios for fixed assets, inventory, and capital suggest underutilization of assets. This could mean the company is not generating enough revenue from its assets, impacting overall operational efficiency. Improving asset utilization is crucial for enhancing profitability.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.52 | 1.63 | 1.06 | 1.34 | 1.62 |
| Inventory Turnover Ratio | 5.01 | 4.05 | 4.8 | 5.45 | 5.81 |
| Receivables Turnover Ratio | 3.88 | 3.12 | 3.48 | 4.47 | 4.8 |
| Days Sales in Inventory Ratio | 72.85 | 90.12 | 76.04 | 66.97 | 62.82 |
| Receivable Days | 94.07 | 116.99 | 104.89 | 81.66 | 76.04 |
| Capital Turnover Ratio | 1.62 | 1.09 | 0.91 | 1.15 | 1.33 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios indicate some challenges in meeting financial obligations. While the interest coverage ratio is adequate, the equity dividend coverage ratio is low, suggesting potential difficulties in covering dividend payouts with available earnings. Improving earnings and managing debt effectively are crucial for ensuring better coverage of financial obligations.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 5.9 | 2.24 | 1.09 | 1.23 | 1.68 |
| Equity Dividend Coverage Ratio | 11.11 | 33.33 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits strong solvency. A high equity ratio and low debt ratios indicate a conservative capital structure, reducing financial risk. This suggests the company relies more on equity than debt to finance its assets, providing a stable financial foundation. While this minimizes risk, it might also limit potential growth opportunities through leveraging debt.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.17 | 0.25 | 0.29 | 0.27 | 0.23 |
| Debt to Equity Ratio | 0.2 | 0.33 | 0.41 | 0.37 | 0.3 |
| Equity Ratio | 0.83 | 0.75 | 0.71 | 0.73 | 0.77 |
| Debt To Asset Ratio | 0.1 | 0.17 | 0.2 | 0.18 | 0.15 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is weak. Low current, quick, and cash ratios suggest difficulties in meeting short-term obligations. While a conservative approach to cash and operating cash flow might contribute to this, it also signals potential challenges in managing immediate liabilities. Maintaining sufficient liquid assets is crucial for operational flexibility and weathering unforeseen financial demands.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.45 | 1.41 | 1.18 | 1.19 | 1.24 |
| Quick Ratio | 0.92 | 0.98 | 0.83 | 0.78 | 0.86 |
| Cash Ratio | 0.02 | 0.03 | 0.04 | 0.04 | 0.02 |
| Operating Cash Flow Ratio | -0.02 | 0.43 | 0.27 | 0.14 | 0.21 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Bhageria Industries Ltd | 8.19 | 21.43 | Neutral | 91.00 | 11.52 | 44.00 |
| 2 | Ducol Organics & Colours Ltd | 7.61 | 24.22 | Neutral | 14.00 | 2.49 | 7.00 |
| 3 | Bodal Chemicals Ltd | 6.19 | 50.41 | Undervalued | 161.00 | 3.74 | 48.00 |
| 4 | Asahi Songwon Colors Ltd | 5.13 | 16.26 | Undervalued | 50.00 | 19.05 | 18.00 |
| 5 | Heubach Colorants India Ltd | 3.63 | 3.18 | Highly Undervalued | 56.00 | 20.21 | 40.00 |
Bodal Chemicals' management effectiveness is a mix of strengths and weaknesses. The company has shown good sales growth and consistent promoter holding, but there are concerns about profit growth, operating profit margin, and financial prudence. Increasing debt and fluctuating cash flows also raise questions. Overall, management's ability to sustain profitability and manage risks needs further scrutiny, resulting in an Orange rating.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (TTM) | 24% | Strong revenue expansion |
| Promoter Holding (Mar 2025) | 57.32% | Indicates confidence and alignment | |
| CONS | Compounded Profit Growth (5Y) | -26% | Profit growth is declining |
| Debt/Equity Ratio (Mar 2025) | 0.79 | Leverage is increasing |
Financial Performance & Growth
Bodal Chemicals has shown inconsistent financial performance. While sales have grown, profit growth has been volatile.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sales Growth (%) | 1.74% | 16.33% | 29.77% | -22.66% | -10.85% | 24.29% |
| Operating Profit (Cr) | 174.33 | 217 | 146.67 | 121 | 108 | 166 |
The company experienced significant sales growth from 2020 to 2022, with a growth rate of 77.99% in March 2022. However, this growth was followed by a decline, with sales decreasing by -22.66% in 2023 and -10.85% in 2024 before rebounding to 24.29% in March 2025. Operating Profit decreased from 189 Cr. in 2014 to 83 Cr. in 2021, before increasing to 224 Cr. in 2022 and decreasing to 166 Cr. in 2025. The OPM has shown a declining trend from 20% in 2014 to 10% in 2025.
Capital Efficiency & Returns
The capital efficiency and returns for Bodal Chemicals are concerning. ROCE has declined significantly over the years.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 37.67% | 33.33% | 9% | 4% | 3% | 5% |
ROCE has decreased significantly from 39% in 2014 to 5% in 2025, indicating that the company's ability to generate returns on its capital employed has weakened considerably. This may be due to various factors, including increased capital expenditure, decreased profitability, or inefficient asset utilization.
Financial Health & Prudence
Bodal Chemicals' financial health exhibits concerning trends. Debt levels have risen, and interest coverage has deteriorated.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings (Cr) | 258 | 141.67 | 438 | 755 | 903 | 911 |
| Interest Coverage Ratio | 4.02 | 34.43 | 4.19 | 3.56 | 0.23 | 0.34 |
The borrowings have increased from 397 Cr. in 2014 to 911 Cr. in 2025. The interest coverage ratio has declined which indicates a decreased ability to meet its interest obligations, signaling potential financial stress. The dividend payout has been inconsistent, with no dividend payout in 2024 and 2025.
Strategic & Operational Indicators
Working capital management presents a mixed picture. While debtor days have generally decreased, inventory days have increased, impacting the cash conversion cycle.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 73.33 | 74 | 125 | 95 | 99 | 84 |
| Inventory Days | 66.67 | 64.33 | 136 | 112 | 128 | 134 |
| Cash Conversion Cycle | 66 | 61 | 149.33 | 131 | 126 | 120 |
Debtor days have decreased from 86 in 2014 to 84 in 2025. Inventory days have increased from 72 in 2014 to 134 in 2025. The cash conversion cycle has increased from 92 in 2014 to 120 in 2025 which indicates the decreased efficiency in managing working capital and converting investments in inventory and receivables into cash.
Bodal Chemicals faces a moderate level of risk due to several factors. The increasing debt levels and decreasing profit margins pose financial risks. Operational risks are indicated by the fluctuating cash conversion cycle and changes in working capital. While the promoter holding remains relatively stable, the decrease in FII and DII holdings increases risk perceptions. Segment performance volatility and contingent liability evaluations needs to be done.
Off-balance sheet exposure quantification
There is no specific data available to quantify off-balance sheet exposure. Therefore, it is difficult to assess the risk associated with items that are not recorded on the company's balance sheet.
Contingent liability evaluation
There is no specific data available to evaluate contingent liabilities. Therefore, a comprehensive risk assessment is not possible.
Accounting quality red flags
There is no specific data available to determine any accounting quality red flags.
Segment performance volatility
There is no specific data available on segment performance volatility. Therefore, a complete analysis is not possible.
Foreign exchange or interest rate exposure
There is no specific data available on foreign exchange or interest rate exposure. Therefore, a complete analysis is not possible.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe